Drawing for INFINIUM PHARMACEUTICALS

USPTO serial 86398358

INFINIUM PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SOUDERS, MICHAEL J
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INFINIUM PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert H. Epstein

ROBERT H. EPSTEIN EPSTEIN & GERKEN14006 Glen Mill RoadROCKVILLE, MD 20850-3179UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 4, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 4, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 4, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2017EX5GSOU EXTENSION 5 GRANTED—
Oct 30, 2017EXT5SOU EXTENSION 5 FILED—
Oct 30, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 2, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 28, 2017EX4GSOU EXTENSION 4 GRANTED—
Apr 28, 2017EXT4SOU EXTENSION 4 FILED—
Apr 28, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 17, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 16, 2016EX3GSOU EXTENSION 3 GRANTED—
Oct 28, 2016EXT3SOU EXTENSION 3 FILED—
Oct 28, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 18, 2016EX2GSOU EXTENSION 2 GRANTED—
Apr 28, 2016EXT2SOU EXTENSION 2 FILED—
Apr 28, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 28, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 27, 2016EX1GSOU EXTENSION 1 GRANTED—
Jan 22, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 3, 2015NREVNOTICE OF REVIVAL - E-MAILED—
Dec 3, 2015TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Dec 3, 2015PETGPETITION TO REVIVE-GRANTED—
Dec 3, 2015PROATEAS PETITION TO REVIVE RECEIVED—
Nov 30, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 30, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 28, 2015EXT1SOU EXTENSION 1 FILED—
Apr 28, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 3, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 11, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 29, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 27, 2015ALIEASSIGNED TO LIE—
Jan 5, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Jan 5, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 5, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 5, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 5, 2015DOCKASSIGNED TO EXAMINER—
Nov 14, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 25, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance